Last updated: 15 June 2019 at 11:35pm EST

David Thompson Net Worth




The estimated Net Worth of David Thompson is at least $12.6 Million dollars as of 28 August 2017. David Thompson owns over 52,472 units of Exact Sciences stock worth over $12,595,989 and over the last 14 years David sold EXAS stock worth over $0.

David Thompson EXAS stock SEC Form 4 insiders trading

David has made over 4 trades of the Exact Sciences stock since 2011, according to the Form 4 filled with the SEC. Most recently David exercised 52,472 units of EXAS stock worth $317,980 on 28 August 2017.

The largest trade David's ever made was exercising 52,472 units of Exact Sciences stock on 28 August 2017 worth over $317,980. On average, David trades about 6,962 units every 149 days since 2010. As of 28 August 2017 David still owns at least 196,444 units of Exact Sciences stock.

You can see the complete history of David Thompson stock trades at the bottom of the page.



What's David Thompson's mailing address?

David's mailing address filed with the SEC is C/O EXACT SCIENCES CORP., 441 CHARMANY DRIVE, MADISON, WI, 53719.

Insiders trading at Exact Sciences

Over the last 21 years, insiders at Exact Sciences have traded over $118,141,352 worth of Exact Sciences stock and bought 191,930 units worth $1,451,887 . The most active insiders traders include Kevin T Conroy, Edwin M Jr Kania, and Maneesh Arora. On average, Exact Sciences executives and independent directors trade stock every 12 days with the average trade being worth of $1,667,056. The most recent stock trade was executed by Brian Baranick on 5 August 2024, trading 2,712 units of EXAS stock currently worth $173,893.



What does Exact Sciences do?

exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences'​ noninvasive colon cancer screening test, visit cologuardtest.com



What does Exact Sciences's logo look like?

Exact Sciences Corp. logo

Complete history of David Thompson stock trades at Exact Sciences

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
28 Aug 2017 David Thompson
Director
Option 52,472 $6.06 $317,980
28 Aug 2017
196,444
14 Dec 2016 David Thompson
Director
Buy 10,000 $13.84 $138,400
14 Dec 2016
136,379
11 Jan 2016 David Thompson
Director
Buy 15,000 $6.99 $104,850
11 Jan 2016
110,213
13 Dec 2011 David Thompson
Director
Buy 20,000 $8.16 $163,200
13 Dec 2011
47,470


Exact Sciences executives and stock owners

Exact Sciences executives and other stock owners filed with the SEC include: